Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis

Claudia De Lalla, Grazia Galli, Luca Aldrighetti, Raffaella Romeo, Margherita Mariani, Antonella Monno, Sandra Nuti, Massimo Colombo, Francesco Callea, Steven A. Porcelli, Paola Panina-Bordignon, Sergio Abrignani, Giulia Casorati, Paolo Dellabona

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

Invariant (inv)NKT cells are a subset of autoreactive lymphocytes that recognize endogenous lipid ligands presented by CD1d, and are suspected to regulate the host response to cell stress and tissue damage via the prompt production of cytokines. We investigated invNKT cell response during the progression of chronic viral hepatitis caused by hepatitis B or C virus infection, a major human disease characterized by a diffused hepatic necroinflammation with scarring fibrotic reaction, which can progress toward cirrhosis and cancer. Ex vivo frequency and cytokine production were determined in circulating and intrahepatic invNKT cells from controls (healthy subjects or patients with nonviral benign or malignant focal liver damage and minimal inflammatory response) or chronic viral hepatitis patients without cirrhosis, with cirrhosis, or with cirrhosis and hepatocellular carcinoma. invNKT cells increase in chronically infected livers and undergo a substantial modification in their effector functions, consisting in the production of the type 2 profibrotic IL-4 and IL-13 cytokines, which characterizes the progression of hepatic fibrosis to cirrhosis. CD1d, nearly undetectable in noncirrhotic and control livers, is strongly expressed by APCs in cirrhotic ones. Furthermore, in vitro CD1d-dependent activation of invNKT cells from healthy donors elicits IL-4 and IL-13. Together, these findings show that invNKT cells respond to the progressive liver damage caused by chronic hepatitis virus infection, and suggest that these cells, possibly triggered by the recognition of CD1d associated with viral- or stress-induced lipid ligands, contribute to the pathogenesis of cirrhosis by expressing a set of cytokines involved in the progression of fibrosis.

Original languageEnglish
Pages (from-to)1417-1425
Number of pages9
JournalJournal of Immunology
Volume173
Issue number2
Publication statusPublished - Jul 15 2004

Fingerprint

Natural Killer T-Cells
Chronic Hepatitis
Fibrosis
Cytokines
Liver
Interleukin-13
Virus Diseases
Interleukin-4
Ligands
Lipids
Hepatitis Viruses
Lymphocyte Subsets
Hepatitis B virus
Hepacivirus
Cicatrix
Hepatocellular Carcinoma
Healthy Volunteers
Tissue Donors

ASJC Scopus subject areas

  • Immunology

Cite this

Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. / De Lalla, Claudia; Galli, Grazia; Aldrighetti, Luca; Romeo, Raffaella; Mariani, Margherita; Monno, Antonella; Nuti, Sandra; Colombo, Massimo; Callea, Francesco; Porcelli, Steven A.; Panina-Bordignon, Paola; Abrignani, Sergio; Casorati, Giulia; Dellabona, Paolo.

In: Journal of Immunology, Vol. 173, No. 2, 15.07.2004, p. 1417-1425.

Research output: Contribution to journalArticle

De Lalla, Claudia ; Galli, Grazia ; Aldrighetti, Luca ; Romeo, Raffaella ; Mariani, Margherita ; Monno, Antonella ; Nuti, Sandra ; Colombo, Massimo ; Callea, Francesco ; Porcelli, Steven A. ; Panina-Bordignon, Paola ; Abrignani, Sergio ; Casorati, Giulia ; Dellabona, Paolo. / Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. In: Journal of Immunology. 2004 ; Vol. 173, No. 2. pp. 1417-1425.
@article{6c6a5ff4829b41da9b4cf753e0b2bfac,
title = "Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis",
abstract = "Invariant (inv)NKT cells are a subset of autoreactive lymphocytes that recognize endogenous lipid ligands presented by CD1d, and are suspected to regulate the host response to cell stress and tissue damage via the prompt production of cytokines. We investigated invNKT cell response during the progression of chronic viral hepatitis caused by hepatitis B or C virus infection, a major human disease characterized by a diffused hepatic necroinflammation with scarring fibrotic reaction, which can progress toward cirrhosis and cancer. Ex vivo frequency and cytokine production were determined in circulating and intrahepatic invNKT cells from controls (healthy subjects or patients with nonviral benign or malignant focal liver damage and minimal inflammatory response) or chronic viral hepatitis patients without cirrhosis, with cirrhosis, or with cirrhosis and hepatocellular carcinoma. invNKT cells increase in chronically infected livers and undergo a substantial modification in their effector functions, consisting in the production of the type 2 profibrotic IL-4 and IL-13 cytokines, which characterizes the progression of hepatic fibrosis to cirrhosis. CD1d, nearly undetectable in noncirrhotic and control livers, is strongly expressed by APCs in cirrhotic ones. Furthermore, in vitro CD1d-dependent activation of invNKT cells from healthy donors elicits IL-4 and IL-13. Together, these findings show that invNKT cells respond to the progressive liver damage caused by chronic hepatitis virus infection, and suggest that these cells, possibly triggered by the recognition of CD1d associated with viral- or stress-induced lipid ligands, contribute to the pathogenesis of cirrhosis by expressing a set of cytokines involved in the progression of fibrosis.",
author = "{De Lalla}, Claudia and Grazia Galli and Luca Aldrighetti and Raffaella Romeo and Margherita Mariani and Antonella Monno and Sandra Nuti and Massimo Colombo and Francesco Callea and Porcelli, {Steven A.} and Paola Panina-Bordignon and Sergio Abrignani and Giulia Casorati and Paolo Dellabona",
year = "2004",
month = "7",
day = "15",
language = "English",
volume = "173",
pages = "1417--1425",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis

AU - De Lalla, Claudia

AU - Galli, Grazia

AU - Aldrighetti, Luca

AU - Romeo, Raffaella

AU - Mariani, Margherita

AU - Monno, Antonella

AU - Nuti, Sandra

AU - Colombo, Massimo

AU - Callea, Francesco

AU - Porcelli, Steven A.

AU - Panina-Bordignon, Paola

AU - Abrignani, Sergio

AU - Casorati, Giulia

AU - Dellabona, Paolo

PY - 2004/7/15

Y1 - 2004/7/15

N2 - Invariant (inv)NKT cells are a subset of autoreactive lymphocytes that recognize endogenous lipid ligands presented by CD1d, and are suspected to regulate the host response to cell stress and tissue damage via the prompt production of cytokines. We investigated invNKT cell response during the progression of chronic viral hepatitis caused by hepatitis B or C virus infection, a major human disease characterized by a diffused hepatic necroinflammation with scarring fibrotic reaction, which can progress toward cirrhosis and cancer. Ex vivo frequency and cytokine production were determined in circulating and intrahepatic invNKT cells from controls (healthy subjects or patients with nonviral benign or malignant focal liver damage and minimal inflammatory response) or chronic viral hepatitis patients without cirrhosis, with cirrhosis, or with cirrhosis and hepatocellular carcinoma. invNKT cells increase in chronically infected livers and undergo a substantial modification in their effector functions, consisting in the production of the type 2 profibrotic IL-4 and IL-13 cytokines, which characterizes the progression of hepatic fibrosis to cirrhosis. CD1d, nearly undetectable in noncirrhotic and control livers, is strongly expressed by APCs in cirrhotic ones. Furthermore, in vitro CD1d-dependent activation of invNKT cells from healthy donors elicits IL-4 and IL-13. Together, these findings show that invNKT cells respond to the progressive liver damage caused by chronic hepatitis virus infection, and suggest that these cells, possibly triggered by the recognition of CD1d associated with viral- or stress-induced lipid ligands, contribute to the pathogenesis of cirrhosis by expressing a set of cytokines involved in the progression of fibrosis.

AB - Invariant (inv)NKT cells are a subset of autoreactive lymphocytes that recognize endogenous lipid ligands presented by CD1d, and are suspected to regulate the host response to cell stress and tissue damage via the prompt production of cytokines. We investigated invNKT cell response during the progression of chronic viral hepatitis caused by hepatitis B or C virus infection, a major human disease characterized by a diffused hepatic necroinflammation with scarring fibrotic reaction, which can progress toward cirrhosis and cancer. Ex vivo frequency and cytokine production were determined in circulating and intrahepatic invNKT cells from controls (healthy subjects or patients with nonviral benign or malignant focal liver damage and minimal inflammatory response) or chronic viral hepatitis patients without cirrhosis, with cirrhosis, or with cirrhosis and hepatocellular carcinoma. invNKT cells increase in chronically infected livers and undergo a substantial modification in their effector functions, consisting in the production of the type 2 profibrotic IL-4 and IL-13 cytokines, which characterizes the progression of hepatic fibrosis to cirrhosis. CD1d, nearly undetectable in noncirrhotic and control livers, is strongly expressed by APCs in cirrhotic ones. Furthermore, in vitro CD1d-dependent activation of invNKT cells from healthy donors elicits IL-4 and IL-13. Together, these findings show that invNKT cells respond to the progressive liver damage caused by chronic hepatitis virus infection, and suggest that these cells, possibly triggered by the recognition of CD1d associated with viral- or stress-induced lipid ligands, contribute to the pathogenesis of cirrhosis by expressing a set of cytokines involved in the progression of fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=3142687525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142687525&partnerID=8YFLogxK

M3 - Article

C2 - 15240738

AN - SCOPUS:3142687525

VL - 173

SP - 1417

EP - 1425

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -